Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Nov;9(6):294-9.
doi: 10.1200/JOP.2013.000982. Epub 2013 Oct 15.

Coaching intervention as a strategy for minority recruitment to cancer clinical trials

Affiliations
Randomized Controlled Trial

Coaching intervention as a strategy for minority recruitment to cancer clinical trials

Paula M Fracasso et al. J Oncol Pract. 2013 Nov.

Abstract

Purpose: Lack of trust and rapport with health care providers has been identified in the under-representation of racial/ethnic minorities within clinical trials. Our study used a coach to promote trust among minority patients with advanced cancer.

Patients and methods: Minority patients with advanced breast, colorectal, lung, or prostate carcinoma were randomly assigned to receive a coach Intervention (CI) or usual care (UC). All patients completed baseline and 6-month telephone interviews to assess demographics, trust in health care providers, attitudes toward clinical trials, and quality of life. Patients randomly assigned to CI were assigned a coach, who made biweekly contacts for 6 months to address general issues, progress or development in cancer care, and available resources. Patients randomly assigned to UC received the standard of care, without this intervention. Clinical trial enrollment was assessed.

Results: Over 21 months, we screened 268 patients and enrolled 73 African Americans and two Asian Americans. Patients were randomly assigned to CI (n = 38) or to UC (n = 37). Longitudinal analyses were conducted on 69 patients who completed the 6-month follow-up assessment. Trial enrollment was 16 and 13 patients for the CI and UC groups, respectively. This difference was not significant (P = .351). Higher quality of life (1-point odds ratio on Functional Assessment of Cancer Treatment-General = 1.033, P = .036) and positive attitudes toward trials predicted enrollment. There was no significant difference between these groups in quality of life, attitudes toward clinical trials, perceptions of racism, trust in doctors, or depression.

Conclusions: Quality of life and positive attitude toward trials predicted trial enrollment, regardless of assignment to CI or UC.

PubMed Disclaimer

References

    1. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002;20:2109–2117. - PubMed
    1. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA. 2004;291:2720–2726. - PubMed
    1. National Patient Advocate Foundation. Baseline study of patient accrual onto publicly sponsored clinical trials: An analysis conducted for the Global Access Project of the National Patient Advocate Foundation, Coalition of Cancer Cooperative Groups (CCCG) 2006. Feb, www.npaf.org/global-access-project.
    1. UyBico SJ, Pavel S, Gross CP. Recruiting vulnerable populations into research: A systematic review of recruitment interventions. J Gen Intern Med. 2007;22:852–863. - PMC - PubMed
    1. Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review. Cancer. 2008;112:228–242. - PubMed

Publication types